Real-world outcomes versus clinical trial results of immunotherapy in stage iv non-small cell lung cancer (nsclc) in the netherlands

HIGHLIGHTS

• who: Christine M. Cramer-van der Welle from the cancer (NSCLC) in the NetherlandsUtrecht University have published the research: Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands, in the Journal: Scientific Reports Scientific Reports of 23/Nov/2020
• what: The study was approved by the Santeon institutional review board, and all clinical information was provided in a de-identified fashion and informed consent was waived (SDB219-008). This study showed that PFS of patients with stage IV NSCLC treated with immunotherapy is . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.